Clinical Trial Update: Study HZA106829: Efficacy/Safety Study of Fluticasone Furoate/Vilanterol (GW642444) in Adult and Adolescent Asthmatics [Phase 3]

View source ↗

Summary

This ClinicalTrials.gov update reports the results of a Phase 3 efficacy and safety study evaluating the inhaled combination fluticasone furoate/vilanterol (GW6…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Fluticasone Furoate/Vilanterol (fluticasone furoate/vilanterol)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Asthma | Phase 3 | Status: COMPLETED | Results posted: 2013-08-08